Google
 

Archive for the ‘Arthritis’ Category

Risk Of Knee Osteoarthritis Progression May Be Reduced By Use Of A Cane

Thursday, May 15th, 2008

A common, incurable joint disease, osteoarthritis (OA) is the leading cause of disability in elderly people. While nearly any joint can be affected, OA most often strikes the knee, particularly the inner aspect of the tibiofemoral joint. One source of stress on this vulnerable joint compartment is the knee adduction ...

Rheumatoid Arthritis: Fully-automated Anti-CCP Assay Launched By Roche Diagnostics

Thursday, May 15th, 2008

Roche Diagnostics announced the launch of a fully-automated immunoassay for the determination of autoantibodies to cyclic citrullinated peptides (Anti-CCP). The assay has been CE approved for use on the Elecsys / cobas e electrochemiluminescence immunoassay systems. The results of the Anti-CCP assay are intended to be used as an ...

A Bit Of Reassurance On Lyme Disease

Thursday, May 15th, 2008

Tick bites generate fears of Lyme disease in every parent, but this study of 99 children finds that one of Lyme's complications -- arthritis -- has a good prognosis. Researchers led by Robert Sundel, MD, a rheumatologist at Children's, found that 77 percent of children were cured with less than ...

NICE And Its Decision Not To Approve Rheumatoid Arthritis Drug Abatacept, UK

Thursday, May 15th, 2008

The failure of the UK National Institute for Clinical Excellence (NICE) to approve treatment of the rheumatoid arthritis (RA) drug abatacept on the National Health Service (NHS) is discussed in the lead Editorial in this week's Lancet. Abatacept, is, with rituximab and tocilizumab, one of three new drug classes that ...

Improving Osteoporosis Care Standards Worldwide: Landmark Observational Study

Thursday, April 10th, 2008

Nearly 60,000 women aged 55 years and older have enrolled in a landmark, multi-national study that will focus on the management of osteoporosis across the globe. Launch of the Global Longitudinal Registry of Osteoporosis in Women (GLOW) was announced at ECCEO 8 (Eighth European Congress on Clinical and Economic Aspects ...

Hit Pain Where It Hurts: Arthritis Care Launches New UK Course

Tuesday, April 8th, 2008

Time to take your life back - that's Arthritis Care's message to 7.8 million* people in the UK who live with chronic day-to-day pain. The 61-year old charity today marks its awareness week (12th-18th April) by launching its new Challenging Pain programme across the country.. Around half of those living ...

Current And Emerging Drugs Have No Advantage Over Enbrel In Inhibiting/Slowing The Progression Of Rheumatoid Arthritis

Tuesday, April 8th, 2008

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a drug's effect on inhibiting/slowing the progression of structural damage and reducing the signs and symptoms of rheumatoid arthritis during the first year of treatment are the attributes that ...

Neurochem Withdraws Its Marketing Authorisation Application For Kiacta(eprodisate Disodium), Europe

Tuesday, March 25th, 2008

The European Medicines Agency (EMEA) has been formally notified byNeurochem Luxco II SARL of its decision to withdraw the application fora centralised marketing authorisation for the medicine Kiacta(eprodisate disodium) capsules.Kiacta was expected to be used for the treatment of amyloid Aamyloidosis, a rare, life-threatening disease that occurs in patientswith long-lasting ...

ACTEMRA Significantly Improves Symptoms For Rheumatoid Arthritis Patients Who Did Not Respond Well To Standard Therapy

Thursday, March 20th, 2008

Patients with rheumatoid arthritis treated with ACTEMRA™ (tocilizumab) experienced a rapid and significant reduction in the signs and symptoms of their disease, according to a study published in this week's issue of The Lancet. Results from the OPTION (TOcilizumab Pivotal Trial in Methotrexate Inadequate respONders) trial a ...

What Causes Rheumatoid Arthritis - How Is Your Heart Affected?

Wednesday, March 19th, 2008

In a recent issue of The Johns Hopkins Arthritis Bulletin, Johns Hopkins specialists reported on the latest research regarding the link between rheumatoid arthritis and heart health. With rheumatoid arthritis, the inflammation that damages joints also takes a toll on the heart. Johns Hopkins specialists offer bottom line advice on ...

MorphoSys Receives CTA Approval To Initiate Phase 1 Clinical Study For MOR103 Program

Monday, March 17th, 2008

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced that the regulatory authorities in the Netherlands have approved the clinical trial application (CTA) to initiate a phase 1 study of the HuCAL-derived antibody MOR103. MorphoSys had submitted the clinical trial application in December 2007. In parallel, MorphoSys has received ...

Some Patients May Be Spared An Unnecessary Procedure By New Test For Joint Infection

Tuesday, March 4th, 2008

A potential diagnostic test that could help surgeons confirm or rule out the presence of infection-causing bacteria in prosthetic joints that require surgical revision has been developed by researchers at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health (NIH). ...

Detecting Bone Erosion In Rheumatoid Arthritis

Thursday, February 28th, 2008

Both magnetic resonance imaging (MRI) and computed tomography (CT) are more sensitive than radiography - the standard imaging technique - for detecting bone erosions in rheumatoid arthritis (RA), according to research published in the open access journal Arthritis Research & Therapy. The early detection of bone erosions is crucial for ...

NICE Launches New Era For Millions With Osteoarthritis, UK

Thursday, February 28th, 2008

In guidelines hailed by Arthritis Care as a giant leap towards more patient-centred services, the National Institute of Health and Clinical Excellence (NICE) today recommends that osteoarthritis (OA) patients needing NHS joint surgery are referred promptly when other treatments have failed them. For the first time, NICE stipulates that ...

Arthritis Sufferers Fund Arthritis Research

Monday, February 18th, 2008

The Queensland and Northern New South Wales Lions Medical Research Foundation, long time supporters of the Brisbane research community, have confirmed funding of $1.2 million for scientists at UQ's Diamantina Institute. Dr Gethin Thomas will be the inaugural recipient of the $300,000 three-year fellowship, which will fund his ...